Current risk assessments are unable to calculate the likelihood of a near-future fracture after a patient breaks their hip.

The University of Oklahoma Health has earned a $3 million grant from the National Cancer Institute for this project.

Annual SAVR volumes in the United States decreased by a whopping 44.5% from 2012 to 2022. However, heart teams across the country seem to agree that surgery is a safer, more effective treatment option than TAVR when patients present with bicuspid aortic valves. 

Injuries to the esophagus remain a common complication associated with radiofrequency ablation procedures. New research suggests a device developed by S4 Medical could significantly reduce the risk of such injuries. 

The group's annual meeting heads to Atlanta this April. TAVR, GLP-1 agonists, medical imaging guidance and blood pressure control are just some of the topics that will be presented during late-breaking sessions.

The study involved an analysis of the genomic data from 5,000 families and could lead to new treatments.

Scientists from Lithuania said the therapy could be helpful for patients struggling with lung damage from COVID-19.

Actinium-225 remains in short supply, slowing drug research.